Pulmonx Corporation
-
Ticker
LUNG
-
Industry
Medical Appliances & Equipment More
-
Sector
Healthcare More
- 201-500 Employees
- Based in Redwood City, California
Pulmonx Corporation (Nasdaq: LUNG) is a global leader in minimally invasive treatments for severe lung disease. Pulmonx’s Zephyr® Endobronchial Valve, Chartis® Pulmonary Assessment System and StratX® Lung Analysis Platform are designed to assess and treat patients with severe emphysema/COPD who despite medical management are still profoundly symptomatic. Pulmonx received FDA pre-market
…More approval to commercialize the Zephyr Valve following its designation as a “breakthrough device.” The Zephyr Valve is commercially available in more than 25 countries, with over 100,000 valves used to treat more than 25,000 patients.
REPORT RATINGS
5.0 / 5.0 (1)
Pulmonx Corporation reports have an aggregate usefulness score of 5.0 based on 1 reviews.
Pulmonx Corporation
Most Recent Responsibility Report
MOST RECENT
2023 Environmental, Social and Governance Summary Report
Report Locked. Pulmonx Corporation has reached its limit for free report views.
Our service enables potential investors to review the most recent and archived Pulmonx Corporation Sustainability Report, Pulmonx Corporation Corporate Social Responsibility Report, Pulmonx Corporation CSR Report, Pulmonx Corporation Corporate Responsibility, Pulmonx Corporation CR Report, Pulmonx Corporation Citizenship Report, Pulmonx Corporation ESG Report, and Pulmonx Corporation Environmental Report online.